Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older

Mayo Clinic Proceedings

Volumn 82, Issue 7, 2007, Pages 822-827

  Zhang, LuXia ^a   Zuo, L ^a   Wang, Fang ^a   Wang, Mei ^a   Wang, ShuYu ^b   Liu, LiSheng ^b   Wang, HaiYan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Beijing Hypertension League Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CHINA; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS; WAIST CIRCUMFERENCE;

EID: 34347328018     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.7.822     Document Type: Article

References (33)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
2. Gu D, Reynolds K, Wu X, et al, InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365:1398-1405.
3. Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl. 2005;94:S63-S67.
4. Dialysis and Transplantation Registration Group CSoNCMA. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol. 2001;17:77-78.
5. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005 Jul;16:2134-2140. Epub 2005 May 18.
6. Zhang L, Zuo L, Xu G, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007 Apr;22:1093-1099. Epub 2007 Jan 8.
7. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003 May 21;289:2560-2572. Epub 2003 May 14.
8. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome part 1: worldwide definition for use in clinical practice. Available at: www.idf.org/webdata/docs/IDF_metasyndrome_definition. pdf. Accessed May 11, 2007.
9. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease [published correction appears in J Am Soc Nephrol. 2006;17:3540]. J Am Soc Nephrol. 2006 Oct;17:2937-2944. Epub 2006 Sep 20.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
11. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167-174.
12. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369-374.
13. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48: 383-391.
14. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans: the Inter-Tribal Heart Project. J Am Soc Nephrol. 2002;13:1626-1634.
15. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003;16(11,pt 1):952-958.
16. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes. 1998; 47:793-800.
17. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med. 1989; 111:788-796.
18. Nelson RG, Bennett PH, Beck GJ, et al, Diabetic Renal Disease Study Group. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med. 1996;335:1636-1642.
19. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine: results from the 'Clue' Study and the ARIC Study. JAMA. 1993;269:488-493.
20. Whelton PK, Perneger TV, He J, Klag MJ. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypertens. 1996;10:683-689.
21. Samuelsson O, Attman PO, Knight-Gibson C, et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol. 1998;9: 1482-1488.
22. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58:293-301.
23. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59:260-269.
24. Rule AD, Rodeheffer RJ, Larson TS, et al. Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc. 2006;81:1427-1434.
25. Results from the Fourth National Health and Nutrition Examination Survey of China. Acta Nutrimenta Sinica. 2004;26:417-420.
26. Liu LS, Chen MQ, Zeng GY, Zhou BF. A forty-year study on hypertension [in Chinese]. Acta Acad Med Sin. 2002;24:401-408.
27. Wu YK, Lu CQ, Gao RQ. Nation-wide hypertension screening in China during 1979-1980. Chin Med J (Engl). 1982;95:101-108.
28. Wu Z, Yao C, Zhao D, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation. 2001;103:462-468.
29. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation. 2003;108:1552-1553.
30. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2, suppl 1):S1-S266.
31. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002; 137:555-562.
32. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137: 563-570.
33. Zhang L, Zuo L, Wang F, et al. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol. 2006 Sep; 17:2617-2621. Epub 2006 Aug 2.